A tumor fighting virus is changed to block a growth signal
Original title: Development and preclinical evaluation of a decoy DLL4-encoding oncolytic HSV-1 for high-grade glioma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
The new virus was only tested in lab dishes and in mice.
The short version
In mice, a changed virus shrank brain tumors and helped them live longer.
What was studied. Scientists work on viruses built to infect and kill brain tumor cells. They added a blocker for a tumor growth signal called Notch, then tested the new virus in lab cells and in mice with glioma: A tumor that starts in the glial cells, the support cells of the brain and spinal cord. Gliomas are given a grade from 1 to 4 describing how the tumor is expected to behave. See the glossary.
What they found. Tumor samples from people showed more of a protein called DLL4 after the older virus. DLL4 turns the Notch signal on. The new virus blocked that signal and slowed the growth of new blood vessels. It grew more slowly in the dish, but it still killed tumor cells. In mice, it shrank the tumor and the mice lived longer.
What this means, and what it doesn't
What it could mean: This is an early step toward making tumor killing viruses work better. It does not change care today. If the work holds up, this virus could be tested in people later.
What it doesn't mean: This does not mean a new treatment is ready. The new virus was tested only in lab cells and in mice. Results in mice often do not hold up in people. It is not a cure, and no doctor can offer it now.
Source: PubMed, September 12, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.